Memorial Sloan Kettering Cancer Center


Standort der Organisation:
New York, NY, Vereinigte Staaten von Amerika (USA)

Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern

Go to first page Go to previous page 3 von 4 Go to next page Go to last page
Chornokur, G., Lin, H.-Y., Tyrer, J.P., Lawrenson, K., Dennis, J., Amankwah, E.K.,... Phelan, C.M. (2015). Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS ONE, 10(6), e0128106.
Lawrenson, K., Iversen, E.S., Tyrer, J., Weber, R.P., Concannon, P., Hazelett, D.J.,... Schildkraut, J.M. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis, 36(11), 1341-53.
Amankwah, E.K., Lin, H.-Y., Tyrer, J.P., Lawrenson, K., Dennis, J., Chornokur, G.,... Phelan, C.M. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology, 39(8), 689-97.
Lee, A.W., Tyrer, J.P., Doherty, J.A., Stram, D.A., Kupryjanczyk, J., Dansonka-Mieszkowska, A.,... Pearce, C.L. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology, 136(3), 542-8.
Johnatty, S.E., Tyrer, J.P., Kar, S., Beesley, J., Lu, Y., Gao, B.,... Chenevix-Trench, G. (2015). Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research, 21(23), 5264-76.
Ye, M., Zhang, H., Yang, H., Koche, R., Staber, P.B., Cusan, M.,... Tenen, D.G. (2015). Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia. Cell Stem Cell, 17(5), 611-23.
Chiappinelli, K.B., Strissel, P., Desrichard, A., Li, H., Henke, C., Akman, B.,... Strick, R. (2015). Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell, 162(5), 974-86.
Daniels, G.H., Hegedus, L., Marso, S.P., Nauck, M.A., Zinman, B., Bergenstal, R.M.,... Tuttle, M. (2015). LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. Diabetes Obesity & Metabolism, 17(5), 477-86.
Kar, S.P., Tyrer, J.P., Li, Q., Lawrenson, K., Aben, K.K.H., Anton-Culver, H.,... Pharoah, P.D.P. (2015). Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiology Biomarkers & Prevention, 24(10), 1574-84.
Lu, Y., Cuellar-Partida, G., Painter, J.N., Nyholt, D.R., Morris, A.P., Fasching, P.A.,... Macgregor, S. (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics, 24(20), 5955-64.
Amin, M.B., Smith, S.C., Reuter, V.E., Epstein, J.I., Grignon, D.J., Hansel, D.E.,... Soloway, M.S. (2015). Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Modern Pathology, 28(5), 612-30.
Amin, M.B., Smith, S.C., Agaimy, A., Argani, P., Comperat, E.M., Delahunt, B.,... Reuter, V.E. (2014). Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. American Journal of Surgical Pathology, 38(7), 871-4.
Kelemen, L.E., Terry, K.L., Goodman, M.T., Webb, P.M., Bandera, E.V., Mcguire, V.,... Le, N.D. (2014). Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research, 58(10), 2023-35.
Earp, M.A., Kelemen, L.E., Magliocco, A.M., Swenerton, K.D., Chenevix-Trench, G., Lu, Y.,... Brooks-Wilson, A. (2014). Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human genetics, 133(5), 481-97.
Marx, A., Stroebel, P., Badve, S.S., Chalabreysse, L., Chan, J.K.C., Chen, G.,... Travis, W.D. (2014). ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. Journal of Thoracic Oncology, 9(5), 596-611.
Charbonneau, B., Moysich, K.B., Kalli, K.R., Oberg, A.L., Vierkant, R.A., Fogarty, Z.C.,... Goode, E.L. (2014). Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research, 2(4), 332-40.
Cortazar, P., Zhang, L., Untch, M., Mehta, K., Costantino, J.P., Wolmark, N.,... Von Minckwitz, G. (2014). Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet, 384(9938), 164-72.
Spurdle, A.B., Couch, F.J., Parsons, M.T., Mcguffog, L., Barrowdale, D., Bolla, M.K.,... Goldgar, D.E. (2014). Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research, 16(6), 3419.
Charbonneau, B., Block, M.S., Bamlet, W.R., Vierkant, R.A., Kalli, K.R., Fogarty, Z.,... Goode, E.L. (2014). Risk of Ovarian Cancer and the NF-?B Pathway: Genetic Association with IL1A and TNFSF10. Cancer Research, 74(3), 852-61.
Block, M.S., Charbonneau, B., Vierkant, R.A., Fogarty, Z., Bamlet, W.R., Pharoah, P.D.P.,... Goode, E.L. (2014). Variation in NF-?B signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology Biomarkers & Prevention, 23(7), 1421-7.

Zuletzt aktualisiert 2016-29-04 um 08:06